AstraZeneca | AstraZeneca | False Claims Act and related | 2009 | KY-AG | $14,700,000 |
AstraZeneca | AstraZeneca | False Claims Act and related | 2018 | TX-AG | $110,000,000 |
AstraZeneca | AstraZeneca | employment discrimination | 2021 | OFCCP | $560,000 |
AstraZeneca | AstraZeneca | drug or medical equipment safety violation | 2010 | private lawsuit-federal | $198,000,000 |
AstraZeneca | AstraZeneca | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $24,000,000 |
AstraZeneca LP | AstraZeneca | off-label or unapproved promotion of medical products | 2010 | FDA | $520,000,000 |
AstraZeneca LP | AstraZeneca | False Claims Act and related | 2015 | DOJ_CIVIL | $7,900,000 |
AstraZeneca LP | AstraZeneca | False Claims Act and related | 2015 | DOJ_CIVIL | $46,500,000 |
AstraZeneca LP | AstraZeneca | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $46,500,000 |
AstraZeneca Pharmaceuticals | AstraZeneca | False Claims Act and related | 2009 | DOJ_CIVIL | $2,600,000 |
AstraZeneca Pharmaceuticals | AstraZeneca | off-label or unapproved promotion of medical products | 2011 | MULTI-AG | $68,500,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | False Claims Act and related | 2003 | DOJ_CIVIL | $354,900,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | False Claims Act and related | 2003 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,900,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,600,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $218,092,993 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $11,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $20,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $13,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $90,000,000 |
AstraZeneca Pharmaceuticals LP and AstraZeneca LP | AstraZeneca | False Claims Act and related | 2011 | ID-AG | $2,500,000 |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
AstraZeneca PLC | AstraZeneca | kickbacks and bribery | 2016 | SEC | $5,522,000 |
ASTRAZENECA PLP | AstraZeneca | environmental violation | 2021 | EPA | $18,960 |
Avanir Pharmaceuticals | Otsuka Pharmaceutical | False Claims Act and related | 2019 | DOJ_CIVIL | $115,874,895 |
Avanir Pharmaceuticals | Otsuka Pharmaceutical | False Claims Act and related | 2019 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,000,000 |
Aventis | Sanofi | False Claims Act and related | 2013 | LA-AG | $7,000,000 |
Aventis Pharmaceutical Inc. | Sanofi | False Claims Act and related | 2009 | DOJ_CIVIL | $95,500,000 |
Aventis Pharmaceutical Inc. | Sanofi | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $40,000,000 |
Aventis Pharmaceutical L.P. | Sanofi | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Aventis Pharmaceuticals | Sanofi | False Claims Act and related | 2019 | IL-AG | $14,708,388 |
Aventis Pharmaceuticals Inc. | Sanofi | False Claims Act and related | 2007 | DOJ_CIVIL | $190,000,000 |
Aventis Pharmaceuticals Inc. | Sanofi | False Claims Act and related | 2007 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,645,600 |
Aventis Pharmaceuticals Inc. | Sanofi | False Claims Act and related | 2010 | NJ-AG | $1,300,000 |
Aventis Pharmaceuticals Inc. | Sanofi | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $40,000,000 |
Aventis Pharmaceuticals Inc. | Sanofi | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $800,000 |
Aventis Pharmaceuticals Inc. | Sanofi | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $3,500,000 |
Aventis Pharmaceuticals Inc. | Sanofi | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Aventis Pharmaceuticals Inc. | Sanofi | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
Aventis Pharmaceuticals, Inc. | Sanofi | price-fixing or anti-competitive practices | 2012 | MULTI-AG | $1,650,000 |
Aventis Pharmaceuticals, Inc. and Aventis Behring, LLC | Sanofi | False Claims Act and related | 2012 | KY-AG | $2,290,000 |
Barr Laboratories Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2017 | private lawsuit-state | $225,000,000 |
BARR LABORATORIES INC. | Teva Pharmaceutical Industries | workplace safety or health violation | 2006 | OSHA | $65,250 |
BARR LABORATORIES, INC. | Teva Pharmaceutical Industries | workplace safety or health violation | 2002 | OSHA | $14,000 |
Barr Laboratories, Inc. and Duramed Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2007 | MA-AG | $2,000,000 |
Barr Pharmaceuticals | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $5,900,000 |
Barr Pharmaceuticals Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2009 | private lawsuit-federal | $13,000,000 |
Barr Pharmaceuticals Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $4,150,000 |
Barr Pharmaceuticals Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $2,100,000 |
Bausch & Lomb | Bausch Health | price-fixing or anti-competitive practices | 2001 | MULTI-AG | $17,500,000 |
Bausch & Lomb Inc. | Bausch Health | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $10,000,000 |
BAUSCH AND LOMB PHARMACEUTICALS, INC. | Bausch Health | workplace safety or health violation | 2000 | OSHA | $7,000 |
Bausch Health | Bausch Health | accounting fraud or deficiencies | 2020 | SEC | $45,000,000 |
Bausch Health Companies Inc. | Bausch Health | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $300,000,000 |
Baxalta US Inc. | Takeda Pharmaceutical | wage and hour violation | 2019 | private lawsuit-state | $4,750,000 |
Baxalta US, Inc. | Takeda Pharmaceutical | environmental violation | 2017 | CA-SCAQMD | $35,000 |
BAXTER HEALTHCARE CORP DBA BAXTER BIOSCIENCE | Takeda Pharmaceutical | workplace safety or health violation | 2011 | OSHA | $195,000 |
Biocryst Pharmaceuticals, Inc. | Biocryst Pharmaceuticals | environmental violation | 2014 | AL-ENV | $11,000 |
Biogen Idec Inc. | Biogen | wage and hour violation | 2005 | WHD | $6,934 |
Biogen Idec Inc. | Biogen | consumer protection violation | 2007 | VT-AG | $10,000 |
Biogen Idec, Inc. | Biogen | wage and hour violation | 2009 | WHD | $49,600 |
BIOGEN IDEC, INC. | Biogen | workplace safety or health violation | 2014 | OSHA | $7,500 |
Biogen Inc. | Biogen | False Claims Act and related | 2022 | DOJ_CIVIL | $900,000,000 |
Biogen Inc. | Biogen | benefit plan administrator violation | 2024 | private lawsuit-federal | $9,750,000 |
Biogen, Inc. | Biogen | False Claims Act and related | 2020 | DOJ_CIVIL | $22,000,000 |
Biovail | Bausch Health | False Claims Act and related | 2013 | LA-AG | $200,000 |
BIOVAIL AMERICAS CORP. | Bausch Health | benefit plan administrator violation | 2012 | EBSA | $10,001 |
Biovail Corporation | Bausch Health | accounting fraud or deficiencies | 2008 | SEC | $10,000,000 |
Biovail Pharmaceuticals Inc. | Bausch Health | kickbacks and bribery | 2009 | USAO | $24,647,876 |
Block Drug Company Incorporated | GlaxoSmithKline | wage and hour violation | 2011 | WHD | $352,773 |
Boehringer Ingelheim | Boehringer Ingelheim | False Claims Act and related | 2012 | LA-AG | $3,250,000 |
Boehringer Ingelheim Animal Health USA Inc. | Boehringer Ingelheim | employment discrimination | 2020 | OFCCP | $379,089 |
Boehringer Ingelheim Corp. | Boehringer Ingelheim | False Claims Act and related | 2005 | TX-AG | $10,000,000 |
Boehringer Ingelheim International | Boehringer Ingelheim | drug or medical equipment safety violation | 2014 | private lawsuit-federal | $650,000,000 |
Boehringer Ingelheim Pharma GmbH | Boehringer Ingelheim | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $27,000,000 |
Boehringer Ingelheim Pharma GmbH | Boehringer Ingelheim | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $73,000,000 |
Boehringer Ingelheim Pharmaceutical, Inc. | Boehringer Ingelheim | labor relations violation | 2004 | NLRB | $50,000 |
BOEHRINGER INGELHEIM PHARMACEUTICALS | Boehringer Ingelheim | aviation safety violation | 2014 | FAA | $15,000 |
Boehringer Ingelheim Pharmaceuticals Inc. | Boehringer Ingelheim | off-label or unapproved promotion of medical products | 2012 | FDA | $95,000,000 |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | off-label or unapproved promotion of medical products | 2017 | MULTI-AG | $13,500,000 |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | False Claims Act and related | 2010 | WI-AG | $7,750,000 |
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Roxane, Inc., Roxane Laboratories, Inc. and Ben Venue Laboratories, Inc. | Boehringer Ingelheim | False Claims Act and related | 2009 | KY-AG | $4,500,000 |
Boehringer Ingelheim Roxane, Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2008 | MA-AG | $1,800,000 |
Boehringer Ingelheim Roxane, Inc. et al. | Hikma Pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
BOEHRINGER INGELHEIM VETMEDICA, INC | Eli Lilly | environmental violation | 2011 | EPA | $900,000 |
BOEHRINGER INGELHEIM VETMEDICA, INC | Eli Lilly | environmental violation | 2012 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $338,475 |
Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | environmental violation | 2012 | EPA | $68,475 |
Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | environmental violation | 2011 | EPA | $300,000 |
Boehringer Ingleheim | Boehringer Ingelheim | False Claims Act and related | 2011 | KS-AG | $1,400,000 |
Boehringer-Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $95,000,000 |
BRISTOL - MYERS SQUIBB MEDICAL IMAGING INC | Bristol-Myers Squibb | environmental violation | 2009 | EPA | $19,538 |
BRISTOL MYERS SQUIBB CO | Bristol-Myers Squibb | environmental violation | 2005 | NJ-ENV | $12,000 |
Bristol Myers Squibb Co. | Bristol-Myers Squibb | False Claims Act and related | 2021 | MULTI-AG | $75,000,000 |
Bristol Myers Squibb Company | Bristol-Myers Squibb | environmental violation | 2008 | EPA | $66,770 |
Bristol Myers Squibb Manufacturing Company | Bristol-Myers Squibb | environmental violation | 2008 | EPA | $52,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | Foreign Corrupt Practices Act | 2015 | SEC | $14,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | drug or medical equipment safety violation | 2007 | DOJ_ANTITRUST | $1,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | environmental violation | 2008 | EPA | $3,650,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | fraud | 2005 | USAO | $300,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2008 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $187,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | off-label or unapproved promotion of medical products | 2016 | MULTI-AG | $19,500,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $55,000,000 |